Regenerative medicine and developmental biology: The role of the extracellular matrix

Anatomical Record - Part B New Anatomist

Volumn 287, Issue 1, 2005, Pages 36-41

  Badylak, Stephen F ^a,b  

^a Department of Surgery ^*  (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Developmental biology; Extracellular matrix; Regenerative medicine; Tissue engineering

Indexed keywords

COLLAGEN; PROTEIN;

CELL DIFFERENTIATION; CELL MIGRATION; DEVELOPMENTAL BIOLOGY; EXTRACELLULAR MATRIX; HUMAN; MAMMAL; MORPHOGENESIS; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SCAR FORMATION; TISSUE DIFFERENTIATION; TISSUE ENGINEERING; TISSUE INJURY; TISSUE REGENERATION; TISSUE REPAIR; TISSUE STRUCTURE; WOUND HEALING;

ANIMALS; DEVELOPMENTAL BIOLOGY; EXTRACELLULAR MATRIX; HUMANS; RECONSTRUCTIVE SURGICAL PROCEDURES; REGENERATIVE MEDICINE;

EID: 29044432711     PISSN: 0003276X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ar.b.20081     Document Type: Review

References (49)

1. Atala A. 2001a. Bladder regeneration by tissue engineering. Br J Urol Int 88:765-770.
2. Atala A. 2001b. Tissue engineering in urology. Curr Urol Rep 2:83-9 2.
3. Atala A. 2002. Future trends in bladder reconstructive surgery. Semin Pediatr Surg 11:134-142.
4. Atala A. 2003. Future perspectives in bladder reconstruction. Adv Exp Med Biol 539:921-940.
5. Badylak SF, Kropp B, McPherson T, Liang H, Snyder PW. 1998. Small intestinal submucosa: a rapidly resorbed bioscaffold for augmentation cystoplasty in a dog model. Tissue Eng 4:379-387.
6. Badylak S, Arnoczky S, Plouhar P, Haut R, Mendenhall V, Clarke R, Horvath C. 1999. Naturally occurring extracellular matrix as a scaffold for musculoskeletal repair. Clin Orthopaed Related Res:S333-S343.
7. Badylak S, Meurling S, Chen M, Spievack A, Simmons-Byrd A. 2000. Resorbable bioscaffold for esophageal repair in a dog model. J Pediatr Surg 35:1097-1103.
8. Badylak S, Kokini K, Tullius B, Simmons-Byrd A, Morff R. 2002. Morphologic study of small intestinal submucosa as a body wall repair device. J Surg Res 103:190-202.
9. Badylak S, Yoder M. 2003. The extracellular matrix as a substrate for stem cell growth and development and tissue repair. In: Burt RK, Marmont AM, editors. Stem cell therapy for autoimmune disease. Georgetown, TX: Landes Bioscience. p 87-91.
10. Badylak S. 2004. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl Immunol 12:367-377.
11. Badylak SF. 2005. Regenerative medicine approach to heart valve replacement. Circulation 111:2715-2716.
12. Badylak SF, Vorp DA, Spievack AR, Simmons-Byrd A, Hauke J, Freytes DO, Thapa A, Gilbert TW, Nieponice A. 2005. Esophageal reconstruction with ECM and muscle tissue in a dog model. J Surg Res 128:87-97.
13. Bano F, Barrington JW, Dyer R. 2005. Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct 16:147-150.
14. Belcher HJ, Zic R. 2001. Adverse effect of porcine collagen interposition after trapeziectomy: a comparative study. J Hand Surg 26:159-164.
15. Beniker D, McQuillan D, Livesey S, Urban RM, Turner TM, Blum B, Hughes K, Haggard WO. 2003. The use of acellular dermal matrix as a scaffold for periosteum replacement. Orthopedics 26:S591-S596.
16. Bissell DM, Stamatoglou SC, Nermut MV, Hughes RC. 1986. Interactions of rat hepatocytes with type IV collagen, fibronectin and laminin matrices: distinct matrix-controlled modes of attachment and spreading. Eur J Cell Biol 40:72-78.
17. Brigido SA, Boc SF, Lopez RC. 2004. Effective management of major lower extremity wounds using an acellular regenerative tissue matrix: a pilot study. Orthopedics 27:S145-S149.
18. Cheung D, Brown L, Sampath R. 2004. Localized inferior orbital fibrosis associated with porcine dermal collagen xenograft orbital floor implant. Ophthal Plast Reconstr Surg 20:257-259.
19. Dejardin LM, Arnoczky SP, Ewers BJ, Haut RC, Clarke R. 2001. Tissue-engineered rotator cuff tendon using porcine small intestinal submucosa: histologic and mechanical evaluation in dogs. Am J Sports Med 29:175-184.
20. Entwistle J, Zhang S, Yang B, Wong C, Li Q, Hall CL, A J, Mowat M, Greenberg AH, Turley EA. 1995. Characterization of the murine gene encoding the hyaluronan receptor RHAMM. Gene 163:233-238.
21. Fassler R, Meyer M. 1995. Consequences of lack of beta 1 integrin gene expression in mice. Genes Dev 9:1896-1908.
22. Harper C. 2001. Permacol: clinical experience with a new biomaterial. Hosp Med 62:90-95.
23. Hirsch E, Iglesias A, Potocnik AJ, Hartmann U, Fassler R. 1996. Impaired migration but not differentiation of haematopoietic stem cells in the absence of beta1 integrins. Nature 380:171-175.
24. Hodde JP, Badylak SF, Brightman AO, Voytik-Harbin SL. 1996. Glycosaminoglycan content of small intestinal submucosa: a bioscaffold for tissue replacement. Tissue Eng 2:209-217.
25. Hodde J, Record R, Tullius R, Badylak S. 2002. Fibronectin peptides mediate HMEC adhesion to porcine-derived extracellular matrix. Biomaterials 23:1841-1848.
26. Humphries MJ, Mould AP, Yamada KM. 1991. Matrix receptors in cell migration. In: Mcdonald JA, Mecham RP, editors. Receptors for extracellular matrix. p 195-253.
27. Li S, Harrison D, Carbonetto S, Fassler R, Smyth N, Edgar D, Yurchenco PD. 2002. Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation. J Cell Biol 157:1279-1290.
28. Li F, Li W, Johnson S, Ingram D, Yoder M, Badylak S. 2004. Low-molecular-weight peptides derived from extracellular matrix as chemoattractants for primary endothelial cells. Endothelium 11:199-206.
29. MacLeod TM, Williams G, Sanders R, Green CJ. 2003. Prefabricated skin flaps in a rat model based on a dermal replacement matrix Permacol. Br J Plast Surg 56:775-783.
30. 2 laser as a method of improving the vascularisation of a permanent collagen implant. Burns 30:704-712.
31. MacLeod TM, Sarathchandra P, Williams G, Sanders R, Green CJ. 2004b. Evaluation of a porcine origin acellular dermal matrix and small intestinal submucosa as dermal replacements in preventing secondary skin graft contraction. Burns 30:431-437.
32. Macleod TM, Williams G, Sanders R, Green CJ. 2005. Histological evaluation of Permacoltrade mark as a subcutaneous implant over a 20-week period in the rat model. Br J Plast Surg 58:518-532.
33. McPherson T, Badylak SF. 1998. Characterization of fibronectin derived from porcine small intestinal submucosa. Tissue Eng 4:75-83.
34. Miyamoto S, Katz BZ, Lafrenie RM, Yamada KM. 1998. Fibronectin and integrins in cell adhesion, signaling, and morphogenesis. Ann NY Acad Sci 857:119-129.
35. Piechota HJ, Dahms SE, Nunes LS, Dahiya R, Lue TF, Tanagho EA. 1998a. In vitro functional properties of the rat bladder regenerated by the bladder acellular matrix graft. J Urol 159:1717-1724.
36. Piechota HJ, Dahms SE, Probst M, Gleason CA, Nunes LS, Dahiya R, Lue TF, Tanagho EA. 1998b. Functional rat bladder regeneration through xenotransplantation of the bladder acellular matrix graft. Br J Urol 81:548-559.
37. Piechota HJ, Gleason CA, Dahms SE, Dahiya R, Nunes LS, Lue TF, Tanagho EA. 1999. Bladder acellular matrix graft: in vivo functional properties of the regenerated rat bladder. Urol Res 27:206-213.
38. Pierschbacher MD, Ruoslahti E. 1984. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309:30-33.
39. Ponce ML, Nomizu M, Delgado MC, Kuratomi Y, Hoffman MP, Powell S, Yamada Y, Kleinman HK, Malinda KM. 1999. Identification of endothelial cell binding sites on the laminin gamma 1 chain. Circ Res 84:688-694.
40. Potocnik AJ, Brakebusch C, Fassler R. 2000. Fetal and adult hematopoietic stem cells require beta1 integrin function for colonizing fetal liver, spleen, and bone marrow. Immunity 12:653-664.
41. Rickey FA, Elmore D, Hillegonds D, Badylak SF, Record R, Simmons-Byrd A. 2000. Re-generation of tissue about an animal-based scaffold: AMS studies of the fate of the scaffold. Nucl Instr Methods Phys Res 172:1097-1103.
42. Saray A. 2003. Porcine dermal collagen (Permacol) for facial contour augmentation: preliminary report. Aesthet Plast Surg 27:368-375.
43. Schwarzbauer JE. 1991. Fibronectin: from gene to protein. Curr Opin Cell Biol 3:786-791.
44. Schwarzbauer J. 1999. Basement membranes: putting up the barriers. Curr Biol 9:R242-R244.
45. Timpl R. 1996. Macromolecular organization of basement membranes. Curr Opin Cell Biol 8:618-624.
46. Timpl R, Brown JC. 1996. Supramolecular assembly of basement membranes. Bioessays 18:123-132.
47. van der Rest MGR. 1992. The collagen family of proteins. FASEB J 5:2814-2823.
48. Werb Z, Vu TH, Rinkenberger JL, Coussens LM. 1999. Matrix-degrading proteases and angiogenesis during development and tumor formation. APMIS 107:11-18.
49. Yamada KM, Kennedy DW. 1984. Dualistic nature of adhesive protein function: fibronectin and its biologically active peptide fragments can autoinhibit fibronectin function. J Cell Biol 99:29-36.